ECOG-ACRIN Cancer Research Group shared a post on X:
“Clinical Trial EA7211/STRASS 2, led in the US by Ken Cardona, is the second randomized study ever performed in retroperitoneal soft tissue sarcoma and is enrolling patients in the US, Europe, Canada, Australia, New Zealand, and Japan!”
More posts featuring ECOG-ACRIN Cancer Research Group.